Minimal residual disease quantification by flow cytometry provides reliable risk stratification in Tcell acute lymphoblastic leukemia

Minimal residual disease quantification by flow cytometry provides reliable risk stratification in T-cell acute lymphoblastic leukemia

23:55 EST 14 Dec 2018 | Nature Publishing

More From BioPortfolio on "Minimal residual disease quantification by flow cytometry provides reliable risk stratification in T-cell acute lymphoblastic leukemia"